Ekso Bionics Holdings, Inc. designs, develops, and markets exoskeleton products. Its exoskeleton technology serves multiple markets and can be utilized both by able-bodied persons and persons with physical disabilities or impairments. Its products include EksoNR, which is a wearable robotic exoskeleton specifically designed to be used in a rehabilitation setting; Ekso Indego Therapy is a modular, adjustable, lightweight, lower-limb powered exoskeleton; Ekso Indego Personal is a lightweight powered lower limb orthosis; Ekso Nomad is a power Knee Ankle Foot Orthosis, and Ekso EVO is a wearable upper body exoskeleton. The Company enables individuals with neurological conditions affecting gait, including acquired brain injury (ABI) and spinal cord injury (SCI), to rehabilitate and to walk again; assist individuals with a range of upper extremity impairments and allow industrial workers to perform difficult repetitive work for extended periods. Its segments include EksoHealth and EksoWorks.
BörsenkürzelEKSO
Name des UnternehmensEkso Bionics Holdings Inc
IPO-datumApr 10, 2013
CEOMr. Scott G. Davis
Anzahl der mitarbeiter61
WertpapierartOrdinary Share
GeschäftsjahresendeApr 10
Addresse101 Glacier Point
StadtSAN RAFAEL
BörseNASDAQ Capital Market Consolidated
LandUnited States of America
Postleitzahl94901
Telefon15109841761
Websitehttps://eksobionics.com/
BörsenkürzelEKSO
IPO-datumApr 10, 2013
CEOMr. Scott G. Davis
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.

Keine Daten